Design of Nanotechnological Carriers for Ocular Delivery of Mangiferin: Preformulation Study.
Molecules
; 27(4)2022 Feb 16.
Article
em En
| MEDLINE
| ID: mdl-35209120
ABSTRACT
(1) Background:
Mangiferin (MGN) is a natural compound, showing anti-inflammatory and antioxidant activities for the potential treatment of eye diseases. The poor physicochemical features of MGN (low solubility and high instability) justify its nanoencapsulation into nanostructured lipid carriers (NLC) to improve its ocular bioavailability. (2)Methods:
Firstly, MGN-NLC were prepared by the high shear homogenization coupled with the ultrasound (HSH-US) method. Finally, unloaded and MGN-loaded NLC were analyzed in terms of ocular tolerance. (3)Results:
MGN-NLC showed good technological parameters suitable for ocular administration (particle size below 200 nm). The ORAC assay was performed to quantify the antioxidant activity of MGN, showing that the antioxidant activity of MGN-NLC (6494 ± 186 µM TE/g) was higher than that of the free compound (3521 ± 271 µM TE/g). This confirmed that the encapsulation of the drug was able to preserve and increase its activity. In ovo studies (HET-CAM) revealed that the formulation can be considered nonirritant. (4)Conclusions:
Therefore, NLC systems are a promising approach for the ocular delivery of MGN.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Portadores de Fármacos
/
Sistemas de Liberação de Medicamentos
/
Nanotecnologia
/
Xantonas
/
Nanoestruturas
Idioma:
En
Revista:
Molecules
Ano de publicação:
2022
Tipo de documento:
Article